Pfizer Says 3 COVID Shots Protect Children Under 5
Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday. Pfizer plans…
FDA Clears Pfizer’s COVID Booster Shot for Ages 5 to 11
The U.S. Food and Drug Administration has authorized the use of a booster shot of Pfizer and BioNTech’s COVID-19 vaccine…
FDA Could Authorize Pfizer’s COVID Booster Shot for Ages 5 to 11 on Tuesday
U.S. health regulators are expected to authorize a booster shot of Pfizer/BioNTech’s COVID-19 vaccine for children aged 5 to 11…
Biden Seeks $10B More for COVID, Despite Billion Vaccines Unused
President Joe Biden is pressing lawmakers to release $10 billion in new COVID funding while potentially half of the two…
Researchers Say Evidence Paxlovid Effective Against Long COVID, Trials Warranted
Additional reports of patients with long COVID who were helped by Pfizer Inc’s oral antiviral treatment Paxlovid offer fresh impetus…
Pfizer: COVID Pill Paxlovid Fails to Prevent Infection of Household Members
Pfizer Inc on Friday said a large trial found that its COVID-19 oral antiviral treatment Paxlovid was not effective at…
FDA Will Review Pfizer, Moderna Requests for COVID Vaccines in Young Kids in June
An advisory panel of experts to the U.S. drug regulator will meet in June to review requests from Pfizer Inc…
Pfizer Seeks Authorization of COVID-19 Booster Shot for Ages 5 to 11
Pfizer Inc and its partner BioNTech SE said on Tuesday that they had submitted an application to the U.S. health…
COVID Pill Paxlovid Demand Lags Due to Complications
Worldwide demand for Pfizer Inc’s oral COVID-19 antiviral treatment Paxlovid has been unexpectedly light due to complicated eligibility requirements, reduced…